Horacio Cabral is an Associate Professor in the Department of Bioengineering, Graduate School of Engineering, The University of Tokyo. He received his PhD in Materials Engineering from The University of Tokyo, in 2007 under the supervision of Prof. Kazunori Kataoka. Dr. Cabral was an Assistant Professor at the Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo until 2010, when he joined the Department of Bioengineering of The University of Tokyo as a Lecturer. In 2014, he was promoted to his current position. Dr. Cabral’s major research interests relate to the development of nanomedicines for diagnosis and therapy, particularly systems directed to intractable cancers. His work has provided basis for several nanomedicines aimed for tumor-targeted therapy and imaging, showing that the design parameters of nanomedicines greatly influence their activity. Some of his formulations loading anticancer agents have proceeded into human clinical studies, showing improved survival and reduced side effects.